Aeluma Announces First Quarter Fiscal 2027 Financial Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Aeluma (ALMU) reported fiscal first-quarter 2027 revenue of $568,000, down from the same quarter a year earlier. For the quarter ended September 30, 2026, revenue compared with $1.385 million a year earlier. Net loss was $3.756 million, or $0.19 per share, versus $1.493 million, or $0.09 per share. Adjusted EBITDA loss widened to $2.742 million from $450,000. Cash and cash equivalents fell to $53.875 million from $56.006 million at June 30, 2026.
Aeluma finalized an Aixtron purchase agreement for a manufacturing system capable of processing 200 mm wafers. It advanced high-speed photodetector and quantum dot laser development and expanded customer discussions, including potential development investments and high-volume opportunities for 2028–2032. Diligence and definitive agreement negotiations continued for up to $30 million in proposed CHIPS funding.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointManufacturing expansion advanced through an Aixtron purchase agreement for a new 200 mm capable system.
- Minor pointTechnology development advanced for high-speed photodetectors and quantum dot lasers, including work with supply-chain partners.
- Minor point. Forward-looking: it has not happened yet and may not happen.Customer discussions expanded around potential development investments and high-volume demand supporting the 2028–2032 AI infrastructure buildout.
- Minor pointCost of revenue fell to $339,000, versus $433,000 last quarter and $701,000 a year earlier.
- Minor pointGeneral and administrative expenses fell sequentially to $1.952 million, but exceeded $1.686 million a year earlier.
2 minor points
- Minor pointInterest income rose to $492,000, versus $359,000 last quarter and $115,000 a year earlier.
- Minor pointStock option exercises provided $174,000, compared with $47,000 in the year-earlier quarter.
Negative
- Moderate pointQuarterly revenue declined to $568,000, versus $582,000 last quarter and $1.385 million a year earlier.
- Moderate pointNet loss reached $3.756 million, narrower than $4.013 million last quarter but wider than $1.493 million a year earlier.
- Moderate pointCHIPS funding of up to $30 million remains proposed, with diligence and definitive agreement negotiations ongoing. 20% of market cap
- Minor pointLoss per share was $0.19, versus $0.22 last quarter and $0.09 a year earlier.
- Minor pointOperating loss was $4.248 million, versus $4.372 million last quarter and $1.608 million a year earlier.
8 minor points
- Minor pointAdjusted EBITDA loss was $2.742 million, versus $2.938 million last quarter and $450,000 a year earlier.
- Minor pointNon-GAAP net loss was $2.380 million, versus $2.705 million last quarter and $437,000 a year earlier.
- Minor pointNon-GAAP loss per share was $0.12, versus $0.15 last quarter and $0.03 a year earlier.
- Minor pointCash and cash equivalents declined to $53.875 million from $56.006 million at June 30, 2026.
- Minor pointOperating cash use increased to $1.746 million, compared with $815,000 in the year-earlier quarter.
- Minor pointStock-based compensation increased to $1.376 million, versus $1.308 million last quarter and $1.056 million a year earlier.
- Minor pointShare-settlement tax payments used $307,000, compared with none in the year-earlier quarter.
- Minor pointBook value per share fell sequentially to $2.84 from $3.06, while exceeding $2.53 a year earlier.
Key Figures
- Revenue
- $0.6 million vs. $1.4 million
- Q1 FY27 vs. Q1 FY26
- Net loss
- $3.8 million vs. $1.5 million
- Q1 FY27 vs. Q1 FY26
- Net loss per share
- ($0.19) vs. ($0.09)
- Basic and diluted; Q1 FY27 vs. Q1 FY26
- Adjusted EBITDA loss
- $2.7 million vs. $0.4 million
- Q1 FY27 vs. Q1 FY26
- Proposed CHIPS funding
- Up to $30 million
- Proposed funding; diligence and definitive agreement negotiations ongoing
- MOCVD system capability
- 200 mm capable
- Purchase agreement with Aixtron
Previous Earnings Reports
-
Reported full-year results and a CHIPS R&D letter of intent for up to $30 million.
-
Reported Q1 FY26 revenue, net loss, adjusted EBITDA loss, and cash balance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
mocvd technical
adjusted ebitda financial
non-gaap financial measures financial
photonic integrated circuits technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Continued Progress in Technology Readiness for AI Datacom Market
Executed Purchase Agreement With Aixtron for MOCVD Capacity Expansion and Large-Diameter Wafer Manufacturing
GOLETA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a semiconductor company specializing in high-performance, scalable technologies for AI, mobile and consumer, defense and aerospace, and quantum, today reported financial results for its first quarter of fiscal 2027 ended September 30, 2026.
Fiscal First Quarter 2027 and Subsequent Highlights
- Increased Technology Readiness: Advanced development of high-speed photodetectors and quantum dot lasers leveraging capabilities at Aeluma and supply chain partners such as Sumitomo Chemical Advanced Technologies.
- Manufacturing Expansion: Finalized a purchase agreement with Aixtron for a new 200 mm capable MOCVD system to expand manufacturing capacity and accelerate development for non-indium-phosphide photonics.
- Customer Engagements: Expanded customer discussions in Datacom and other markets regarding product opportunities and non-recurring engineering investments. Several initiatives involve potentially high-volume demand to support the 2028 through 2032 AI infrastructure buildout.
- CHIPS Funding: Continued diligence and definitive agreement negotiations with the U.S. Department of Commerce CHIPS R&D Office for up to
$30 million in proposed funding for development and commercialization of photonics for AI and Advanced Computing.
Management Commentary
“The current U.S. AI infrastructure buildout continues to progress and is expected to reach an aggregate investment of
“Demand for photonic components includes lasers, modulators, photodetectors, and photonic integrated circuits or PICs. Supply chains are constrained, including indium phosphide substrate production and wafer fab capacity. Adopting proven strategies from consumer markets, Aeluma’s technology instead leverages gallium arsenide or silicon substrates, and existing fabs that are already qualified for large-volume markets.”
“As we progress through fiscal 2027, we remain focused on technology and product development for AI Datacom opportunities. Aeluma’s high-speed photodetectors and quantum dot lasers continue to attract customer attention. Our efforts include working with supply chain partners such as Sumitomo Chemical Advanced Technologies to ready technology in a production environment, and investment in MOCVD manufacturing capacity. Lastly, we continue to expand our customer discussions including negotiations on potential development investments and potentially large-volume product opportunities.”
Fiscal First Quarter 2027 Financial Results
- Revenue was
$0.6 million , compared with$1.4 million in the first quarter of fiscal 2026, generated primarily from R&D contracts. - Net loss was
$3.8 million , or ($0.19 ) per basic and diluted share, compared with a net loss of$1.5 million , or ($0.09 ) per basic and diluted share, for the same period last year. - Adjusted EBITDA loss was
$2.7 million , compared with an adjusted EBITDA loss of$0.4 million in the same period last year. - Cash and cash equivalents totaled
$53.9 million at September 30, 2026, compared with$56.0 million at June 30, 2026.
Conference Call and Webcast
Aeluma will host a conference call at 2:00 p.m. Pacific Time and 5:00 p.m. Eastern Time on November 12, 2026 to discuss the Company’s financial results and business outlook. Interested participants may access the call by dialing (833) 890-6767 (domestic) or (412) 564-6155 (international) and referencing “Aeluma”.
A live webcast of the call will also be available on the “Investors” section of Aeluma’s website. The live webcast can also be accessed by clicking here. A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.
Annual Meeting of Stockholders
Aeluma’s 2026 Annual Meeting of Stockholders will be held virtually on November 19, 2026 at 9:00 a.m. Pacific Time. Stockholders of record as of September 23, 2026 are entitled to vote. Additional information regarding the Annual Meeting, including voting and virtual attendance instructions, is available in Aeluma’s definitive proxy statement filed with the SEC on September 30, 2026.
Note about Non-GAAP Financial Measures
This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.
This press release includes non-GAAP financial measures, including:
- Non-GAAP net income (loss), which is defined as GAAP net income (loss) plus stock-based compensation expenses; and
- Adjusted EBITDA, defined as non-GAAP net income (loss) plus depreciation and amortization expenses, less interest income.
A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.
About Aeluma, Inc.
Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.
Company:
Aeluma, Inc.
(805) 351-2707
info@aeluma.com
Investor Contact:
Financial Profiles, Inc.
Moira Conlon
(310) 622-8220
ir@aeluma.com
| Aeluma, Inc. and Subsidiary Condensed Consolidated Balance Sheets | ||||||||
| ($ in thousands) | September 30, 2026 (unaudited) | June 30, 2026 | ||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 53,875 | $ | 56,006 | ||||
| Accounts receivable | 504 | 340 | ||||||
| Prepaids and other current assets | 716 | 965 | ||||||
| Total current assets | 55,095 | 57,311 | ||||||
| Property and equipment: | ||||||||
| Equipment | 2,590 | 2,338 | ||||||
| Leasehold improvements | 547 | 547 | ||||||
| Accumulated depreciation | (1,598 | ) | (1,469 | ) | ||||
| Property and equipment, net | 1,539 | 1,416 | ||||||
| Right-of-use asset - operating | 1,868 | 1,916 | ||||||
| Other assets | 21 | 21 | ||||||
| Total assets | $ | 58,523 | $ | 60,664 | ||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 368 | $ | 341 | ||||
| Accrued expenses and other current liabilities | 1,502 | 1,369 | ||||||
| Lease liability - operating, current portion | 183 | 180 | ||||||
| Total current liabilities | 2,053 | 1,890 | ||||||
| Lease liability - operating, long-term portion | 1,795 | 1,842 | ||||||
| Total liabilities | 3,848 | 3,732 | ||||||
| Commitments and contingencies | - | - | ||||||
| Stockholders’ equity: | ||||||||
| Preferred stock | - | - | ||||||
| Common stock | 2 | 2 | ||||||
| Additional paid-in capital | 84,234 | 82,735 | ||||||
| Accumulated deficit | (29,561 | ) | (25,805 | ) | ||||
| Total stockholders’ equity | 54,675 | 56,932 | ||||||
| Total liabilities and stockholders’ equity | $ | 58,523 | $ | 60,664 | ||||
| Aeluma, Inc. and Subsidiary Condensed Consolidated Statements of Operations (unaudited) | ||||||||||||
| Three Months Ended | ||||||||||||
| ($ in thousands, except per share data) | September 30, 2026 | June 30, 2026 | September 30, 2025 | |||||||||
| Revenue | $ | 568 | $ | 582 | $ | 1,385 | ||||||
| Operating expenses: | ||||||||||||
| Cost of revenue | 339 | 433 | 701 | |||||||||
| Research and development | 2,274 | 606 | ||||||||||
| General and administrative | 1,952 | 2,247 | 1,686 | |||||||||
| Total operating expenses | 4,816 | 4,954 | 2,993 | |||||||||
| Loss from operations | (4,248 | ) | (4,372 | ) | (1,608 | ) | ||||||
| Other income: | ||||||||||||
| Interest income | 492 | 359 | 115 | |||||||||
| Total other income | 492 | 359 | 115 | |||||||||
| Loss before income tax expense | (3,756 | ) | (4,013 | ) | (1,493 | ) | ||||||
| Income tax expense | - | - | - | |||||||||
| Net loss | $ | (3,756 | ) | $ | (4,013 | ) | $ | (1,493 | ) | |||
| Net loss per share – basic and diluted | $ | (0.19 | ) | $ | (0.22 | ) | $ | (0.09 | ) | |||
| Weighted average common shares outstanding - basic and diluted | 19,270,622 | 18,603,331 | 16,141,153 | |||||||||
| Book value per share | $ | 2.84 | $ | 3.06 | $ | 2.53 | ||||||
| Aeluma, Inc. and Subsidiary Condensed Consolidated Statements of Cash Flows (unaudited) | ||||||||
| Three Months Ended September 30, | ||||||||
| ($ in thousands) | 2026 | 2025 | ||||||
| Operating activities: | ||||||||
| Net loss | $ | (3,756 | ) | $ | (1,493 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-based compensation expense | 1,376 | 1,056 | ||||||
| Depreciation and amortization expense | 130 | 102 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (164 | ) | (286 | ) | ||||
| Prepaids and other current assets | 249 | (196 | ) | |||||
| Other assets | (1 | ) | (8 | ) | ||||
| Accounts payable | 27 | (88 | ) | |||||
| Accrued expenses and other current liabilities | 393 | 98 | ||||||
| Net cash used in operating activities | (1,746 | ) | (815 | ) | ||||
| Investing activities: | ||||||||
| Purchase of equipment | (252 | ) | (210 | ) | ||||
| Net cash used in investing activities | (252 | ) | (210 | ) | ||||
| Financing activities: | ||||||||
| Proceeds from stock option exercise | 174 | 47 | ||||||
| Proceeds from public offering, net of offering costs | - | 23,385 | ||||||
| Payment for taxes related to net share settlement of stock options and restricted stock units | (307 | ) | - | |||||
| Net cash provided by (used in) financing activities | (133 | ) | 23,432 | |||||
| Net change in cash and cash equivalents | (2,131 | ) | 22,407 | |||||
| Cash and cash equivalents, beginning of period | 56,006 | 15,740 | ||||||
| Cash and cash equivalents, end of period | $ | 53,875 | $ | 38,147 | ||||
| Supplemental non-cash disclosures: | ||||||||
| Right-of-use asset - operating obtained in exchange for lease liability - operating | $ | - | $ | 274 | ||||
| Aeluma, Inc. and Subsidiary Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited) | ||||||||||||
| Three Months Ended | ||||||||||||
| ($ in thousands, except per share data) | September 30, 2026 | June 30, 2026 | September 30, 2025 | |||||||||
| GAAP net loss | $ | (3,756 | ) | $ | (4,013 | ) | $ | (1,493 | ) | |||
| Non-GAAP adjustments: | ||||||||||||
| Stock-based compensation | 1,376 | 1,308 | 1,056 | |||||||||
| Total adjustments to GAAP net loss | 1,376 | 1,308 | 1,056 | |||||||||
| Non-GAAP net loss | $ | (2,380 | ) | $ | (2,705 | ) | $ | (437 | ) | |||
| Depreciation & amortization | 130 | 126 | 102 | |||||||||
| Interest income | (492 | ) | (359 | ) | (115 | ) | ||||||
| Adjusted EBITDA | $ | (2,742 | ) | $ | (2,938 | ) | $ | (450 | ) | |||
| GAAP net loss per share – basic and diluted | $ | (0.19 | ) | $ | (0.22 | ) | $ | (0.09 | ) | |||
| Non-GAAP adjustments | 0.07 | 0.07 | 0.06 | |||||||||
| Non-GAAP net loss per share – basic and diluted | $ | (0.12 | ) | $ | (0.15 | ) | $ | (0.03 | ) | |||
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Aeluma's fiscal first-quarter 2027 financial results?
Aeluma reported $568,000 in revenue and a $3.756 million net loss, or $0.19 per basic and diluted share, for the quarter ended September 30, 2026. In the year-earlier quarter, revenue was $1.385 million and net loss was $1.493 million, or $0.09 per share.
Has Aeluma secured the proposed CHIPS funding?
The up to $30 million in CHIPS funding remains proposed. Aeluma continued diligence and definitive agreement negotiations with the U.S. Department of Commerce CHIPS R&D Office for development and commercialization of photonics for AI and Advanced Computing.
Who can vote at Aeluma's 2026 annual stockholder meeting?
Stockholders of record as of September 23, 2026 are entitled to vote at Aeluma's virtual annual meeting on November 19, 2026, at 9:00 a.m. Pacific Time. Voting and virtual attendance instructions are available in the definitive proxy statement filed with the SEC on September 30, 2026.